JAMES MAJOR, MD
Ophthalmology Physician · HOUSTON, TX
Individual Active NPI 1700076783
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 977 | 19,204 | $13,105,525 | $3,975,730 | $3,136,985 |
| 2023 | 1,076 | 17,995 | $13,822,113 | $4,381,492 | $3,449,582 |
| 2022 | 1,108 | 14,437 | $8,741,797 | $4,128,689 | $3,253,355 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 3,885 | $147 | $117 |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 3,180 | $29 | $23 |
| 92134 | Imaging of retina | 2,221 | $42 | $31 |
| J0177 | Injection, aflibercept hd, 1 mg | 2,168 | $331 | $264 |
| J0178 | Injection, aflibercept, 1 mg | 1,718 | $823 | $655 |
| J2778 | Injection, ranibizumab, 0.1 mg | 1,672 | $155 | $123 |
| 67028 | Injection of drug into eye | 1,615 | $130 | $99 |
| 92014 | Established patient complete exam of visual system | 1,360 | $129 | $93 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 411 | $226 | $180 |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 301 | $202 | $161 |
| 92250 | Photography of the retina | 190 | $37 | $28 |
| J3590 | Unclassified biologics | 76 | $2,661 | $2,116 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | N2637 | TX |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | N2637 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Texas
- NPI 1295817609
- NPI 1023436896
- NPI 1588815468
- NPI 1437254976
- NPI 1477290617
- NPI 1619491941
- NPI 1336405463
- NPI 1811519358
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.